HCMT
VNDA icon

Highland Capital Management (Texas)’s Vanda Pharmaceuticals VNDA Stock Holding History

Highland Capital Management (Texas)’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-123,090
Closed -$2M – 305
2014
Q1 		$2M Buy
+123,090
New +$1.75M 0.08% 127
2013
Q4 		– Sell
-219,941
Closed -$2.41M – 234
2013
Q3 		$2.41M Buy
+219,941
New +$2.35M 0.16% 77

Other funds holding VNDA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
SCA
Signpost Capital Advisors New York $34.2M AUM 5.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Highland Capital Management (Texas)'s VNDA Position: Q2 2014 in Review

Highland Capital Management (Texas) sold out of Vanda Pharmaceuticals (VNDA) in Q2 2014, closing a stake of 123,090 shares — an estimated $2M sold.

Highland Capital Management (Texas) first reported a position in VNDA in Q3 2013 and held it in 2 quarters. The position peaked at $2.41M in Q3 2013. 110 funds tracked by Wall St. Rank hold VNDA as of Q2 2014.

  • Highland Capital Management (Texas) reported no remaining Vanda Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 123,090 Vanda Pharmaceuticals shares in Q2 2014, an estimated $2M.
  • Highland Capital Management (Texas) first reported a position in Vanda Pharmaceuticals in Q3 2013 and held it in 2 quarters.
  • Highland Capital Management (Texas)'s Vanda Pharmaceuticals position peaked at $2.41M in Q3 2013.
  • 110 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2014.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2014, filed 14 Aug 2014.